Herman Gill
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Peptidase Inhibition and Analysis
Most-Cited Works
- → Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats(2011)202 cited
- → [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease(2019)128 cited
- → Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET(2010)105 cited
- → Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection(2019)94 cited
- → Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET(2020)78 cited
- → Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice(2016)55 cited
- → A Modular Platform for the Rapid Site-Specific Radiolabeling of Proteins with 18F Exemplified by Quantitative Positron Emission Tomography of Human Epidermal Growth Factor Receptor 2(2009)47 cited
- → Preparation of 18F-labeled peptides using the copper(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition(2011)46 cited
- → The Development of Peptide-Based Tools for the Analysis of Angiogenesis(2011)44 cited
- → Enhanced Tumor Retention of a Radiohalogen Label for Site-Specific Modification of Antibodies(2013)43 cited